Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
Salivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.603717/full |
id |
doaj-8e29fac9cffc4f738a08d63fbb703c93 |
---|---|
record_format |
Article |
spelling |
doaj-8e29fac9cffc4f738a08d63fbb703c932021-02-22T05:26:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.603717603717Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic AdenomaTakayoshi Suzuki0Satoshi Kano1Masanobu Suzuki2Shinichiro Yasukawa3Takatsugu Mizumachi4Nayuta Tsushima5Kanako C. Hatanaka6Yutaka Hatanaka7Yoshihiro Matsuno8Akihiro Homma9Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanClinical Research & Medical Innovation Center, Hokkaido University Hospital, Sapporo, JapanDepartment of Surgical Pathology, Hokkaido University Hospital, Sapporo, JapanDepartment of Surgical Pathology, Hokkaido University Hospital, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanSalivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer have been reported, with significant differences in HER2 expression between Ca-ex-PA and de novo. We assessed the differences in gene expression between onset classifications. We conducted immunohistochemical analysis and HER2-DISH for 23 patients and classified SDCs into three subtypes as follows: “HER2-positive” (HER2+/any AR), “Luminal-AR” (HER2-/AR+), and “Basal-like” (HER2-/AR-). We assessed the expression levels of 84 functional genes for 19 patients by using a qRT-PCR array. Ten cases were classified as HER2-positive, seven cases as Luminal-AR, and six cases as Basal-like. The gene expression pattern was generally consistent with the corresponding immunostaining classification. The expression levels of VEGFA, ERBB2(HER2), IGF1R, RB1, and XBP1 were higher, while those of SLIT2 and PTEN were lower in Ca-ex-PA than in de novo. The functions of those genes were concentrated in angiogenesis and AKT/PI3K signaling pathway (Fisher’s test: p-value = 0.025 and 0.004, respectively). Multiple machine learning methods, OPLS-DA, LASSO, and RandomForest, also show that VEGFA can be a candidate for the characteristic differences between Ca-ex-PA and de novo. In conclusion, the AKT/PI3K signaling pathway leading to angiogenesis was hyper-activated in all SDCs, particularly in those classified into the Ca-ex-PAs. VEGFA was over-expressed significantly in the Ca-ex-PA, which can be a crucial factor in the malignant conversion to SDC.https://www.frontiersin.org/articles/10.3389/fonc.2020.603717/fullsalivary duct carcinomacarcinoma ex-pleomorphic adenomaVEGFAHER2machine learning |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Takayoshi Suzuki Satoshi Kano Masanobu Suzuki Shinichiro Yasukawa Takatsugu Mizumachi Nayuta Tsushima Kanako C. Hatanaka Yutaka Hatanaka Yoshihiro Matsuno Akihiro Homma |
spellingShingle |
Takayoshi Suzuki Satoshi Kano Masanobu Suzuki Shinichiro Yasukawa Takatsugu Mizumachi Nayuta Tsushima Kanako C. Hatanaka Yutaka Hatanaka Yoshihiro Matsuno Akihiro Homma Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma Frontiers in Oncology salivary duct carcinoma carcinoma ex-pleomorphic adenoma VEGFA HER2 machine learning |
author_facet |
Takayoshi Suzuki Satoshi Kano Masanobu Suzuki Shinichiro Yasukawa Takatsugu Mizumachi Nayuta Tsushima Kanako C. Hatanaka Yutaka Hatanaka Yoshihiro Matsuno Akihiro Homma |
author_sort |
Takayoshi Suzuki |
title |
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma |
title_short |
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma |
title_full |
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma |
title_fullStr |
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma |
title_full_unstemmed |
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma |
title_sort |
enhanced angiogenesis in salivary duct carcinoma ex-pleomorphic adenoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-02-01 |
description |
Salivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer have been reported, with significant differences in HER2 expression between Ca-ex-PA and de novo. We assessed the differences in gene expression between onset classifications. We conducted immunohistochemical analysis and HER2-DISH for 23 patients and classified SDCs into three subtypes as follows: “HER2-positive” (HER2+/any AR), “Luminal-AR” (HER2-/AR+), and “Basal-like” (HER2-/AR-). We assessed the expression levels of 84 functional genes for 19 patients by using a qRT-PCR array. Ten cases were classified as HER2-positive, seven cases as Luminal-AR, and six cases as Basal-like. The gene expression pattern was generally consistent with the corresponding immunostaining classification. The expression levels of VEGFA, ERBB2(HER2), IGF1R, RB1, and XBP1 were higher, while those of SLIT2 and PTEN were lower in Ca-ex-PA than in de novo. The functions of those genes were concentrated in angiogenesis and AKT/PI3K signaling pathway (Fisher’s test: p-value = 0.025 and 0.004, respectively). Multiple machine learning methods, OPLS-DA, LASSO, and RandomForest, also show that VEGFA can be a candidate for the characteristic differences between Ca-ex-PA and de novo. In conclusion, the AKT/PI3K signaling pathway leading to angiogenesis was hyper-activated in all SDCs, particularly in those classified into the Ca-ex-PAs. VEGFA was over-expressed significantly in the Ca-ex-PA, which can be a crucial factor in the malignant conversion to SDC. |
topic |
salivary duct carcinoma carcinoma ex-pleomorphic adenoma VEGFA HER2 machine learning |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2020.603717/full |
work_keys_str_mv |
AT takayoshisuzuki enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT satoshikano enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT masanobusuzuki enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT shinichiroyasukawa enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT takatsugumizumachi enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT nayutatsushima enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT kanakochatanaka enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT yutakahatanaka enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT yoshihiromatsuno enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma AT akihirohomma enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma |
_version_ |
1724257028180803584 |